Literature DB >> 25525477

Protein restriction in hepatic encephalopathy is appropriate for selected patients: a point of view.

Douglas L Nguyen1, Timothy Morgan1.   

Abstract

Since the late nineteenth century, protein restriction has been shown to improve hepatic encephalopathy. However, malnutrition has been described in up to 60 % of cirrhotic patients and is associated with increased mortality. Furthermore, emerging clinical evidence has revealed that a large proportion of cirrhotic patients may tolerate normal protein intake. However, approximately one third of cirrhotic patients with hepatic encephalopathy may need a short course of protein restriction, in addition to maximum medical therapy, to ameliorate the clinical course of their hepatic encephalopathy. For patients with chronic hepatic encephalopathy who are protein-sensitive, modifying their sources of nitrogen by using more vegetable protein, less animal protein, and branched-chain amino acids may improve their encephalopathy without further loss of lean body mass. In conclusion, among cirrhotics with hepatic encephalopathy, modulation of normal protein intake must take into account the patient's hepatic reserve, severity of hepatic encephalopathy, and current nutritional status.

Entities:  

Keywords:  Hepatic encephalopathy; Malnutrition; Protein diet

Year:  2014        PMID: 25525477      PMCID: PMC4267851          DOI: 10.1007/s12072-013-9497-1

Source DB:  PubMed          Journal:  Hepatol Int        ISSN: 1936-0533            Impact factor:   6.047


  40 in total

1.  Dietary management of hepatic encephalopathy in cirrhotic patients: survey of current practice in United Kingdom.

Authors:  C T Soulsby; M Y Morgan
Journal:  BMJ       Date:  1999-05-22

2.  Protein-calorie malnutrition in liver cirrhosis.

Authors:  H U Lautz; O Selberg; J Körber; M Bürger; M J Müller
Journal:  Clin Investig       Date:  1992-06

3.  Blood ammonia levels following the ingestion of casein and whole blood.

Authors:  A N BESSMAN; G S MIRICK
Journal:  J Clin Invest       Date:  1958-07       Impact factor: 14.808

Review 4.  Astrocytic-ammonia interactions in hepatic encephalopathy.

Authors:  M D Norenberg
Journal:  Semin Liver Dis       Date:  1996-08       Impact factor: 6.115

5.  Synergism between mercaptans and ammonia or fatty acids in the production of coma: a possible role for mercaptans in the pathogenesis of hepatic coma.

Authors:  L Zieve; W M Doizaki; J Zieve
Journal:  J Lab Clin Med       Date:  1974-01

6.  Effect of dietary protein manipulation in subclinical portal-systemic encephalopathy.

Authors:  K M de Bruijn; L M Blendis; D H Zilm; P L Carlen; G H Anderson
Journal:  Gut       Date:  1983-01       Impact factor: 23.059

7.  Beneficial effect of vegetable protein diet supplemented with psyllium plantago in patients with hepatic encephalopathy and diabetes mellitus.

Authors:  M Uribe; M Dibildox; S Malpica; E Guillermo; A Villallobos; L Nieto; F Vargas; G Garcia Ramos
Journal:  Gastroenterology       Date:  1985-04       Impact factor: 22.682

Review 8.  Food-based strategies to modulate the composition of the intestinal microbiota and their associated health effects.

Authors:  D Bosscher; A Breynaert; L Pieters; N Hermans
Journal:  J Physiol Pharmacol       Date:  2009-12       Impact factor: 3.011

9.  Protein-calorie malnutrition as a prognostic indicator of mortality among patients hospitalized with cirrhosis and portal hypertension.

Authors:  Justina Sam; Geoffrey C Nguyen
Journal:  Liver Int       Date:  2009-07-07       Impact factor: 5.828

10.  Effect of physiologic hyperinsulinemia on glucose and lipid metabolism in cirrhosis.

Authors:  A S Petrides; L C Groop; C A Riely; R A DeFronzo
Journal:  J Clin Invest       Date:  1991-08       Impact factor: 14.808

View more
  7 in total

Review 1.  Nutrition and Muscle in Cirrhosis.

Authors:  Anil C Anand
Journal:  J Clin Exp Hepatol       Date:  2017-11-08

Review 2.  Sarcopenia in chronic liver disease: mechanisms and countermeasures.

Authors:  Sophie L Allen; Jonathan I Quinlan; Amritpal Dhaliwal; Matthew J Armstrong; Ahmed M Elsharkawy; Carolyn A Greig; Janet M Lord; Gareth G Lavery; Leigh Breen
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2020-11-25       Impact factor: 4.052

3.  A New Look at Precipitants of Overt Hepatic Encephalopathy in Cirrhosis.

Authors:  Ganesh Pantham; Anthony Post; Deepak Venkat; Douglas Einstadter; Kevin D Mullen
Journal:  Dig Dis Sci       Date:  2017-05-30       Impact factor: 3.199

Review 4.  Sarcopenia from mechanism to diagnosis and treatment in liver disease.

Authors:  Srinivasan Dasarathy; Manuela Merli
Journal:  J Hepatol       Date:  2016-08-08       Impact factor: 25.083

5.  Dietary Regulation of the Gut Microbiota Engineered by a Minimal Defined Bacterial Consortium.

Authors:  Ting-Chin David Shen; Christel Chehoud; Josephine Ni; Evelyn Hsu; Ying-Yu Chen; Aubrey Bailey; Alice Laughlin; Kyle Bittinger; Frederic D Bushman; Gary D Wu
Journal:  PLoS One       Date:  2016-05-13       Impact factor: 3.240

6.  Effects of a high protein diet and liver disease in an in silico model of human ammonia metabolism.

Authors:  Jeddidiah W D Griffin; Patrick C Bradshaw
Journal:  Theor Biol Med Model       Date:  2019-07-31       Impact factor: 2.432

Review 7.  Nutrition principles and recommendations in different types of hepatic encephalopathy.

Authors:  Monika Pazgan-Simon; Jolanta Zuwała-Jagiełło; Sylwia Serafińska; Krzysztof Simon
Journal:  Clin Exp Hepatol       Date:  2016-02-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.